Skip to main content
Industry News
Drug development startup Hexagon Bio raises $47M
9/16/2020

Hexagon Bio, a biotech startup that studies fungus for potential medicinal uses, raised $47 million in its Series A funding round. With the new capital it will move forward with its drug discovery research.

Full Story: